These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25848982)

  • 21. Inactivation of RARβ inhibits Wnt1-induced mammary tumorigenesis by suppressing epithelial-mesenchymal transitions.
    Liu X; Giguère V
    Nucl Recept Signal; 2014; 12():e004. PubMed ID: 25422594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
    Chan TW; Pollak M; Huynh H
    Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion.
    DiGiovanni J; Bol DK; Wilker E; Beltrán L; Carbajal S; Moats S; Ramirez A; Jorcano J; Kiguchi K
    Cancer Res; 2000 Mar; 60(6):1561-70. PubMed ID: 10749124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling.
    Ravid D; Maor S; Werner H; Liscovitch M
    Oncogene; 2005 Feb; 24(8):1338-47. PubMed ID: 15592498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surface-expressed insulin receptors as well as IGF-I receptors both contribute to the mitogenic effects of human insulin and its analogues.
    Lundby A; Bolvig P; Hegelund AC; Hansen BF; Worm J; Lützen A; Billestrup N; Bonnesen C; Oleksiewicz MB
    J Appl Toxicol; 2015 Jul; 35(7):842-50. PubMed ID: 25413577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential Effects of Insulin and IGF1 Receptors on ERK and AKT Subcellular Distribution in Breast Cancer Cells.
    Sarfstein R; Nagaraj K; LeRoith D; Werner H
    Cells; 2019 Nov; 8(12):. PubMed ID: 31771180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proliferative and signaling activities of insulin analogues in endometrial cancer cells.
    Aizen D; Sarfstein R; Bruchim I; Weinstein D; Laron Z; Werner H
    Mol Cell Endocrinol; 2015 May; 406():27-39. PubMed ID: 25697343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin growth factor-I and epidermal growth factor receptors recruit distinct upstream signaling molecules to enhance AKT activation in mammary epithelial cells.
    Fleming JM; Desury G; Polanco TA; Cohick WS
    Endocrinology; 2006 Dec; 147(12):6027-35. PubMed ID: 16990343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral pain is enhanced by insulin-like growth factor 1 and its receptors in a mouse model of type 2 diabetes mellitus.
    Tang Z; Cao F; Zhang H; Tang J; Li H; Zhang Y; Feng B; Wang H
    J Diabetes; 2019 Apr; 11(4):309-315. PubMed ID: 30105862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-like growth factor-1 receptor-mediated inhibition of A-type K(+) current induces sensory neuronal hyperexcitability through the phosphatidylinositol 3-kinase and extracellular signal-regulated kinase 1/2 pathways, independently of Akt.
    Wang H; Qin J; Gong S; Feng B; Zhang Y; Tao J
    Endocrinology; 2014 Jan; 155(1):168-79. PubMed ID: 24080365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer.
    Webster NJ; Resnik JL; Reichart DB; Strauss B; Haas M; Seely BL
    Cancer Res; 1996 Jun; 56(12):2781-8. PubMed ID: 8665514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors.
    Wu Y; Cui K; Miyoshi K; Hennighausen L; Green JE; Setser J; LeRoith D; Yakar S
    Cancer Res; 2003 Aug; 63(15):4384-8. PubMed ID: 12907608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell lineage-specific signaling of insulin and insulin-like growth factor I in rabbit blastocysts.
    Navarrete Santos A; Ramin N; Tonack S; Fischer B
    Endocrinology; 2008 Feb; 149(2):515-24. PubMed ID: 17962341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human IGF1 pro-forms induce breast cancer cell proliferation via the IGF1 receptor.
    De Santi M; Annibalini G; Barbieri E; Villarini A; Vallorani L; Contarelli S; Berrino F; Stocchi V; Brandi G
    Cell Oncol (Dordr); 2016 Apr; 39(2):149-59. PubMed ID: 26701791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermal growth factor and hepatocyte growth factor cooperate to enhance cell proliferation, scatter, and invasion in murine mammary epithelial cells.
    Accornero P; Miretti S; Starvaggi Cucuzza L; Martignani E; Baratta M
    J Mol Endocrinol; 2010 Feb; 44(2):115-25. PubMed ID: 19850646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice.
    White DE; Cardiff RD; Dedhar S; Muller WJ
    Oncogene; 2001 Oct; 20(48):7064-72. PubMed ID: 11704830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a novel primary mammary tumor cell line reveals that cyclin D1 is regulated by the type I insulin-like growth factor receptor.
    Jones RA; Campbell CI; Petrik JJ; Moorehead RA
    Mol Cancer Res; 2008 May; 6(5):819-28. PubMed ID: 18505926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mice expressing myrAKT1 in the mammary gland develop carcinogen-induced ER-positive mammary tumors that mimic human breast cancer.
    Blanco-Aparicio C; Pérez-Gallego L; Pequeño B; Leal JF; Renner O; Carnero A
    Carcinogenesis; 2007 Mar; 28(3):584-94. PubMed ID: 17050554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
    Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.